eXoZymes(EXOZ)
$4.00-0.04 (-0.99%)
EXOZ
eXoZymes financials statements
$4.00
At close:-0.04 (-0.99%)
Want to see EXOZ full AI Analyst Report?
eXoZymes (EXOZ) Ratios
16 Followers
eXoZymes Ratios
EXOZ's free cash flow for Q2 2026 was $-1.64M. For the 2026 fiscal year, EXOZ's free cash flow was increased by $0.00 and operating cash flow was $-1.64M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.51 | 8.12 | 0.50 | 2.32 | 2.61 |
| Quick Ratio | 2.51 | 8.12 | 0.50 | 2.32 | 2.61 |
| Cash Ratio | 1.94 | 7.29 | 0.03 | 0.88 | 1.37 |
| Solvency Ratio | -3.45 | -2.14 | -0.47 | -0.95 | -1.00 |
| Operating Cash Flow Ratio | -4.15 | -6.38 | -0.49 | -1.98 | -3.96 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 1.37M | $ 8.21M | $ -2.73M | $ 156.11K | $ -102.68K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.21 | 0.11 | 0.45 | 0.23 | 0.31 |
| Debt-to-Equity Ratio | 0.37 | 0.13 | -4.19 | 0.44 | 0.60 |
| Debt-to-Capital Ratio | 0.27 | 0.12 | 1.31 | 0.31 | 0.38 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.76 | 1.25 | -9.26 | 1.96 | 1.96 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.15 | 0.17 | 0.20 | 0.07 | 0.09 |
| Net Debt to EBITDA | 0.20 | 1.49 | -0.97 | -0.04 | -0.15 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 98.86% | 100.00% | 102.12% | 104.77% | 100.00% |
| EBT Per EBIT | 95.34% | 98.81% | 111.13% | 99.99% | 93.52% |
| Return on Assets (ROA) | -153.37% | -44.97% | -57.28% | -51.98% | -51.54% |
| Return on Equity (ROE) | -269.59% | -56.25% | 530.39% | -101.72% | -101.00% |
| Return on Capital Employed (ROCE) | -220.60% | -50.70% | -157.12% | -64.97% | -66.46% |
| Return on Invested Capital (ROIC) | -203.05% | -49.72% | -131.28% | -60.68% | -62.19% |
| Return on Tangible Assets | -153.37% | -44.97% | -57.28% | -51.98% | -51.54% |
| Earnings Yield | -10.03% | -4.37% | -2.90% | -1.99% | -1.72% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.29 | 0.00 | 0.38 | 0.22 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -1261.69 | 0.00 | -953.06 | -1642.34 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 1261.69 | 0.00 | 953.06 | 1642.34 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.78 | -1.05 | -0.15 | -0.15 | -0.20 |
| Free Cash Flow Per Share | -0.80 | -1.10 | -0.18 | -0.18 | -0.25 |
| Dividend Paid and CapEx Coverage Ratio | -38.27 | -21.45 | -4.09 | -6.76 | -3.75 |
| Capital Expenditure Coverage Ratio | -38.27 | -21.45 | -4.09 | -6.76 | -3.75 |
| Operating Cash Flow Coverage Ratio | -5.23 | -6.13 | -0.73 | -2.06 | -2.20 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -7.30% | -6.64% | -2.09% | -2.05% | -2.86% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -10.00 | -22.92 | -34.49 | -50.35 | -58.14 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 26.89 | 12.87 | -182.93 | 51.22 | 58.73 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -13.69 | -15.06 | -47.84 | -48.72 | -34.99 |
| Price-to-Operating Cash Flow Ratio | -14.05 | -15.77 | -59.53 | -55.92 | -44.31 |
| Price-to-Earnings Growth (PEG) Ratio | -0.19 | -0.12 | -0.73 | -3.78 | 0.00 |
| Enterprise Value Multiple | -9.98 | -22.48 | -44.92 | -59.38 | -61.30 |
| Enterprise Value | 89.56M | 125.77M | 71.85M | 70.35M | 70.47M |
| EV to EBITDA | -9.98 | -22.48 | -44.92 | -59.38 | -61.30 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -13.42 | -14.13 | -48.89 | -48.75 | -35.07 |
| EV to Operating Cash Flow | -13.77 | -14.79 | -60.84 | -55.96 | -44.42 |
| Tangible Book Value Per Share | 0.41 | 1.28 | -0.05 | 0.17 | 0.15 |
| Shareholders’ Equity Per Share | 0.41 | 1.28 | -0.05 | 0.17 | 0.15 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.00 | -0.02 | -0.05 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -1.09 | -0.72 | -0.25 | -0.17 | -0.15 |
| Tax Burden | 0.99 | 1.00 | 1.02 | 1.05 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.11 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.71 | 1.45 | 0.58 | 0.90 | 1.31 |
Currency in USD
